Acupuncture for Prediabetes With Combined Obesity
NCT06359418 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 260
Last updated 2025-08-22
Summary
The clinical trial aims to evaluate the efficacy and safety of acupuncture in reducing weight and waist circumference while modulating glucose and lipid metabolism in Prediabetes with Combined Obesity.
Conditions
- Obesity
- Abdominal Obesity
- PreDiabetes
Interventions
- DEVICE
-
Acupuncture
The acupuncture needle (size 0.30x40mm) will be inserted into DU20, EX-HN3 and GB8 acupoints at the depth of 15-30mm; The acupuncture needle (size 0.30x50mm or size 0.30x75mm) will be inserted into other acupoints at the depth of 40-70mm; Manipulation will be done after insertion (6 times of small amplitude and uniform twist).
- DEVICE
-
Sham acupuncture
The acupuncture needle (size 0.20x25mm) will be inserted into all acupoints at the depth of 2mm without any manipulation.
Sponsors & Collaborators
-
Hubei Hospital of Traditional Chinese Medicine
collaborator OTHER -
Guangdong Provincial Hospital of Chinese Medicine, Zhuhai
collaborator UNKNOWN -
The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine
collaborator OTHER -
Dongfang Hospital Beijing University of Chinese Medicine
collaborator OTHER -
Linyi Hospital of Traditional Chinese Medicine
collaborator UNKNOWN -
The Second Affiliated Hospital of Guizhou University of Traditional Chinese Medicine
collaborator UNKNOWN -
Xi'an Traditional Chinese Medicine Hospital
collaborator OTHER -
Qingdao Traditional Chinese Medicine Hospital
collaborator UNKNOWN -
Xi'an Hospital of Traditional Chinese Medicine
collaborator OTHER -
Heilongjiang Academy of traditional Chinese Medicine
collaborator UNKNOWN -
The Affiliated Hospital of Qingdao University
collaborator OTHER -
Yantai Hospital of Traditional Chinese Medicine
collaborator UNKNOWN -
Shaanxi Hospital of Traditional Chinese Medicine
collaborator OTHER -
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
lead OTHER
Principal Investigators
-
Zhishun Liu, PhD · Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 64 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-03-01
- Primary Completion
- 2027-06-01
- Completion
- 2028-04-01
Countries
- China
Study Locations
More Related Trials
-
Efficacy and Safety of ZT006 in Overweight and Obese Participants
NCT07230132 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Phase 1 Study of DD01 in Overweight/Obese Subjects With T2DM and NAFLD
NCT04812262 ·Status: COMPLETED ·Phase: PHASE1
-
Phase II Study of THDBH120 Injection in Overweight or Obese Subjects
NCT07036601 ·Status: RECRUITING ·Phase: PHASE2
-
A Study of ZT002 Injection With Subjects With Overweight or Obesity
NCT07020884 ·Status: COMPLETED ·Phase: PHASE2
-
Phase Ib Clinical Study of HDM1005 Injection
NCT06637020 ·Status: COMPLETED ·Phase: PHASE1
-
β-hydroxy-β-methylbutyrate-enriched Nutritional Supplements for Obesity Adults
NCT04953936 ·Status: UNKNOWN ·Phase: NA
-
A Study of LY3437943 in Chinese Participants With Obesity Or Overweight
NCT05548231 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of LY3502970 in Chinese Participants With Obesity or Are Overweight With Weight-related Comorbidities
NCT06023095 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of the Efficacy and Safety of Efsubaglutide Alfa in Overweight or Obesity Patients
NCT06732960 ·Status: COMPLETED ·Phase: PHASE2
-
A Research Study of How NNC0174-0833 Behaves in Japanese and Caucasian Volunteers Who Are Normal Weight, Overweight or With Obesity
NCT03787225 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in People With Overweight or Obesity to Test How BI 1820237, BI 456906, or a Combination of Both Affects Brain Activity
NCT06352424 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of Liraglutide in the Treatment of Obesity Combined With Metabolism Associated Fatty Liver Disease
NCT06501326 ·Status: RECRUITING ·Phase: PHASE4
-
Phase II Clinical Study of HDM1005 Injection in Obese Adults Without Diabetes Mellitus
NCT06886126 ·Status: RECRUITING ·Phase: PHASE2
-
Pharmacokinetics of Benaglutide Injection in Overweight/Obese Adults
NCT05226000 ·Status: COMPLETED ·Phase: PHASE1
-
Effect and Safety of Benaglutide or Metformin in Patients With Simple Obesity Who Have Inadequate Weight Control
NCT03593668 ·Status: UNKNOWN ·Phase: PHASE4
-
A Research Study of How the Medicine NNC0480-0389 Taken With Semaglutide Works in the Body of Healthy Chinese Men
NCT05498610 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of TG103 Injection in Overweight/Obese Subjects Without Diabetes
NCT04855292 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of HRS9531 Injection in Obese Subjects Without Diabetes
NCT05881837 ·Status: COMPLETED ·Phase: PHASE2
-
This is a Multi-centre, Multi-drug, Platform Study in Chinese Participants Living With Obesity / Overweight
NCT07017179 ·Status: RECRUITING ·Phase: PHASE2
-
A Study of BGM0504 Injection in Participants with Obesity or Overweight
NCT06704581 ·Status: RECRUITING ·Phase: PHASE3
-
Multiple Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of THDBH120 in Chinese Patients With Obesity
NCT06951945 ·Status: COMPLETED ·Phase: PHASE1
-
HRS9531 Controls Weight Regain in Obese Subjects
NCT06287437 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Study of BGM1812 Injection in Healthy and Non-diabetic Overweight or Obese Chinese Participants
NCT07294235 ·Status: RECRUITING ·Phase: PHASE1
-
This Study Will Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of MET097 in Adult Participants With Overweight or Obesity
NCT06857617 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Research Study on How a Dose of NNC0662-0419 Works in Japanese, Chinese and Non-Asian Participants Living With Overweight or Obesity
NCT07101783 ·Status: COMPLETED ·Phase: PHASE1